The brain is one of the body’s most energy-demanding organs, accounting for 2 percent of the body’s weight but consuming 20 ...

First-ever clinical trial exclusively conducted among people with hard-to-treat form of tuberculosis known as pre-extensively ...

The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer immunotherapy ...

The 2025 Breakthrough Prize in Life Sciences has been awarded to five scientists for the discovery and characterization of the hormone glucagon-like peptide-1, or GLP-1 — findings that subsequently ...

In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long endeavor reached fruition in the form of a new treatment, CASGEVY, approved by ...

The ubiquity of love across societies and its endurance across millennia is likely rooted in something basic and primal to human nature, Schwartz and Olds say. While it’s unclear whether being head ...

At a glance: Study explains long-standing question of why Huntington’s disease symptoms typically do not appear until midlife even though patients are born with the mutation. Analyses reveal that the ...

New AI model identifies possible therapies from existing medicines for thousands of diseases, including rare ones with no current treatments. The AI tool generates new insights on its own, applies ...

At a glance: New study of nearly 2,000 former NFL players found that 34 percent think they have CTE, a condition it is not yet possible to confirm in a living person. Former players who believed they ...

Scientists at Harvard Medical School have designed a versatile, ChatGPT-like AI model capable of performing an array of diagnostic tasks across multiple forms of cancers. The new AI system, described ...

For decades, the military has used autonomous weapons such as mines, torpedoes, and heat-guided missiles that operate based on simple reactive feedback without human control. However, artificial ...